Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations.

Mass isotopomer distribution analysis (MIDA) is a technique for measuring the synthesis of biological polymers. First developed approximately eight years ago, MIDA has been used for measuring the synthesis of lipids, carbohydrates, and proteins. The technique involves quantifying by mass spectrometry the relative abundances of molecular species of a polymer differing only in mass (mass isotopomers), after introduction of a stable isotope-labeled precursor. The mass isotopomer pattern, or distribution, is analyzed according to a combinatorial probability model by comparing measured abundances to theoretical distributions predicted from the binomial or multinomial expansion. For combinatorial probabilities to be applicable, a labeled precursor must therefore combine with itself in the form of two or more repeating subunits. MIDA allows dilution in the monomeric (precursor) and polymeric (product) pools to be determined. Kinetic parameters can then be calculated (e.g., replacement rate of the polymer, fractional contribution from the endogenous biosynthetic pathway, absolute rate of biosynthesis). Several issues remain unresolved, however. We consider here the impact of various deviations from the simple combinatorial probability model of biosynthesis and describe the analytic requirements for successful use of MIDA. A formal mathematical algorithm is presented for generating tables and equations (APPENDIX), on the basis of which effects of various confounding factors are simulated. These include variations in natural isotope abundances, isotopic disequilibrium in the precursor pool, more than one biosynthetic precursor pool, incorrect values for number of subunits present, and concurrent measurement of turnover from exogenously labeled polymers. We describe a strategy for testing whether isotopic inhomogeneity (e.g., an isotopic gradient or separate biosynthetic sites) is present in the precursor pool by comparing higher-mass (multiply labeled) to lower-mass (single- and double-labeled) isotopomer patterns. Also, an algebraic correction is presented for calculating fractional synthesis when an incomplete ion spectrum is monitored, and an approach for assessing the sensitivity of biosynthetic parameters to measurement error is described. The different calculation algorithms published for MIDA are compared; all share a common model, use overlapping solutions to computational problems, and generate identical results. Finally, we discuss the major practical issue for using MIDA at present: quantitative inaccuracy of instruments. The nature and causes of analytic inaccuracy, strategies for evaluating instrument performance, and guidelines for optimizing accuracy and reducing impact on biosynthetic parameters are suggested. Adherence to certain analytic guidelines, particularly attention to concentration effects on mass isotopomer ratios and maximizing enrichments in the isotopomers of interest, reduces error. Improving instrument accuracy for quantification of isotopomer ratios is perhaps the highest priority for this field. In conclusion, MIDA remains the "equation for biosynthesis," but attention to potentially confounding factors and analytic performance is required for optimal application.

[1]  Molecular ion fragmentation and its effects on mass isotopomer abundances of fatty acid methyl esters ionized by electron impact , 1999, Journal of the American Society for Mass Spectrometry.

[2]  D. J. Millward,et al.  Protein turnover in mammalian tissues and in the whole body , 1978 .

[3]  J Rosenblatt,et al.  Comparison of mass isotopomer dilution methods used to compute VLDL production in vivo. , 1996, The American journal of physiology.

[4]  O. Park,et al.  Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. , 1992, The Biochemical journal.

[5]  M. Hellerstein,et al.  Measuring protein synthesis by mass isotopomer distribution analysis (MIDA). , 1999, Analytical biochemistry.

[6]  M. Hellerstein,et al.  Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. , 1992, The American journal of physiology.

[7]  M. Hellerstein,et al.  The inhibition of gluconeogenesis following alcohol in humans. , 1998, The American journal of physiology.

[8]  M. Hellerstein,et al.  Measurement of de novo hepatic lipogenesis in humans using stable isotopes. , 1991, The Journal of clinical investigation.

[9]  J. Wahren,et al.  Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. , 1991, The Journal of biological chemistry.

[10]  J. Schwarz,et al.  Gas‐phase acid–base chemistry and its effects on mass isotopomer abundance measurements of biomolecular ions , 1998 .

[11]  W. Mook,et al.  The measuring procedure and corrections for the high-precision mass-spectrometric analysis of isotopic abundance ratios, especially referring to carbon, oxygen and nitrogen , 1973 .

[12]  J. Kelleher,et al.  Model equations for condensation biosynthesis using stable isotopes and radioisotopes. , 1992, The American journal of physiology.

[13]  G. Hetényi,et al.  Correction for the metabolic exchange of 14C for 12C atoms in the pathway of gluconeogenesis in vivo. , 1982, Federation proceedings.

[14]  P. Deines,et al.  Chapter 9 – THE ISOTOPIC COMPOSITION OF REDUCED ORGANIC CARBON , 1980 .

[15]  J. I. Seeman,et al.  Conformational analysis through selective isotopic substitution: supersonic jet spectroscopic determination of the minimum energy conformation of o-xylene , 1992 .

[16]  M. Brown,et al.  Effect of alterations of the specific activity of the intracellular acetyl CoA pool on apparent rates of hepatic cholesterogenesis. , 1974, Journal of lipid research.

[17]  M. Hellerstein,et al.  Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans. , 1993, Journal of lipid research.

[18]  M. Hellerstein,et al.  CALCULATIONS FOR GLUCONEOGENESIS BY MASS ISOTOPOMER DISTRIBUTION ANALYSIS , 1995 .

[19]  M. McCarthy,et al.  Prohormone Convertase 1 in Obesity, Gestational Diabetes Mellitus, and NIDDM: No Evidence for a Major Susceptibility Role , 1998, Diabetes.

[20]  M. Hellerstein,et al.  Sampling the lipogenic hepatic acetyl-CoA pool in vivo in the rat. Comparison of xenobiotic probe to values predicted from isotopomeric distribution in circulating lipids and measurement of lipogenesis and acetyl-CoA dilution. , 1991, The Journal of biological chemistry.

[21]  R. Wolfe,et al.  Tracers in metabolic research: radioisotope and stable isotope/mass spectrometry methods. , 1985, Laboratory and research methods in biology and medicine.

[22]  H. Brunengraber,et al.  Nonhomogeneous labeling of liver mitochondrial acetyl-CoA. , 1991, The Journal of biological chemistry.

[23]  R. Wolfe,et al.  Concentration dependence of methyl palmitate isotope ratios by electron impact ionization gas chromatography/mass spectrometry. , 1993, Biological mass spectrometry.

[24]  M. Hellerstein Relationship between precursor enrichment and ratio of excess M2/excess M1 isotopomer frequencies in a secreted polymer. , 1991, The Journal of biological chemistry.

[25]  V. Large,et al.  Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose. , 1995, The American journal of physiology.

[26]  H. Brunengraber,et al.  Limitations of the Mass Isotopomer Distribution Analysis of Glucose to Study Gluconeogenesis , 1995, The Journal of Biological Chemistry.

[27]  D. B. Zilversmit,et al.  The design and analysis of isotope experiments. , 1960, The American journal of medicine.

[28]  M. Hellerstein,et al.  Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. , 1993, The American journal of physiology.

[29]  P. Srere,et al.  Complexities of metabolic regulation. , 1994, Trends in biochemical sciences.

[30]  M. Hellerstein,et al.  Gluconeogenesis and Intrahepatic Triose Phosphate Flux in Response to Fasting or Substrate Loads. APPLICATION OF THE MASS ISOTOPOMER DISTRIBUTION ANALYSIS TECHNIQUE WITH TESTING OF ASSUMPTIONS AND POTENTIAL PROBLEMS (*) , 1995, The Journal of Biological Chemistry.

[31]  K. Marsh,et al.  Glucose homeostasis in children with falciparum malaria: precursor supply limits gluconeogenesis and glucose production. , 1997, The Journal of clinical endocrinology and metabolism.

[32]  E. Bergner,et al.  Testing gas chromatographic/mass spectrometric systems for linearity of response , 1995 .

[33]  D. Chinkes,et al.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. , 1996, The Journal of clinical investigation.

[34]  E. Bergner,et al.  Mass isotopomer pattern and precursor-product relationship. , 1992, Biological mass spectrometry.

[35]  M. Hentze,et al.  Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells. , 1991, Biochimica et biophysica acta.

[36]  J. Kelleher,et al.  Isotopomer spectral analysis of cholesterol synthesis: applications in human hepatoma cells. , 1994, The American journal of physiology.

[37]  M. Hellerstein,et al.  Regulation of hepatic de novo lipogenesis in humans. , 1996, Annual review of nutrition.